Insider Sales Update: Emerald Green Trust Reduces XOS Holding to 1.64M Shares
Rhea-AI Filing Summary
Emerald Green Trust, acting as a director-related reporting person for Xos, Inc. (XOS), reported three scheduled sales of common stock executed under a Rule 10b5-1 trading plan adopted May 27, 2025. The sales occurred on 08/29/2025 (19,731 shares at a weighted average price of $2.8889), 09/02/2025 (24,593 shares at $2.6191) and 09/03/2025 (19,333 shares at $2.4764). Following these dispositions the reporting person beneficially owned 1,637,197 shares. The filings state the price ranges for each sale date and note that full per-price breakdowns are available upon request.
Positive
- Transactions executed under a 10b5-1 plan, indicating pre-established trading instructions.
- Full weighted-average prices and price ranges disclosed with offer to provide per-price breakdowns on request.
- Form signed by trustee, showing formal authorization and compliance with filing requirements.
Negative
- Beneficial ownership decreased from 1,681,123 to 1,637,197 shares following the sales.
- Sales occurred at declining weighted-average prices across the three reported dates ($2.8889 to $2.4764).
Insights
TL;DR: Insider sold 63,657 shares under a pre-established 10b5-1 plan, reducing beneficial ownership to 1,637,197 shares.
The Form 4 discloses routine dispositions under a Rule 10b5-1 plan adopted May 27, 2025. The report provides weighted average prices and price ranges for each execution date and confirms the transactions were sales (code S). The filing is a standard Section 16 disclosure showing depletion of holdings from 1,681,123 to 1,637,197 shares across three dates but does not provide motives beyond the 10b5-1 plan. For investors this is a transparent, pre-planned disposition rather than an ad hoc sale.
TL;DR: Reported trades were executed pursuant to a pre-existing 10b5-1 plan and were signed by the trustee.
The filing identifies Emerald Green Trust as the reporting person and shows the signature of Sarah Bardo as trustee dated 09/03/2025. The disclosure includes the relationship checkbox indicating a director and confirms the plan affirmative-defense box was checked. The document supplies the requisite weighted-average pricing and offers to provide detailed per-price sale breakdowns on request, meeting typical Form 4 compliance standards.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 19,333 | $2.4764 | $48K |
| Sale | Common Stock | 24,593 | $2.6191 | $64K |
| Sale | Common Stock | 19,731 | $2.8889 | $57K |
Footnotes (1)
- The transaction being reported was effected pursuant to a previously established Rule 10b5-1 trading plan adopted by the Reporting Person on May 27, 2025. Represents weighted average sales price. The shares were sold at prices ranging from $2.84 to $3.00. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Represents weighted average sales price. The shares were sold at prices ranging from $2.54 to $2.80. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Represents weighted average sales price. The shares were sold at prices ranging from $2.39 to $2.61. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.